Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

Teva Pharma Industries Ltd ADR (TEVA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Teva ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
16.38 +0.09    +0.52%
20:59:59 - Closed. Currency in USD
After Hours
16.35
-0.02
-0.12%
22:19:18 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 9,349,035
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 16.08 - 16.39
Teva ADR 16.38 +0.09 +0.52%

TEVA Recent Sentiments

 
This page features our user's sentiments regarding the Teva Pharma Industries Ltd ADR share. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Aug 08, 2025 vadim Vadim   16.17 +1.30%
Aug 08, 2025 Yoni Leibel   16.21 -1.05%
Aug 07, 2025 Matan Fridman   16.29 +0.55%
Aug 07, 2025 שלומי בדןסה   16.24 Aug 08, 2025 @ 16.17 -0.43%
Aug 07, 2025 יוסף ישועה   16.38 0.00%
Aug 06, 2025 Oz Musay   15.87 +3.21%
Aug 05, 2025 יהודה מור   15.58 +5.13%
Aug 05, 2025 Yossi Daniel   15.58 -5.13%
Aug 04, 2025 REUVEN KARGER   15.66 -4.60%
Aug 04, 2025 Rorr Ro   15.66 +4.60%
Aug 04, 2025 אברהם כפיר   15.66 -4.60%
Aug 04, 2025 yor ram   15.55 +5.34%
Aug 04, 2025 Jesus Alonso Bueno   15.56 -5.27%
Aug 04, 2025 Yaniv Znaty   15.63 +4.80%
Aug 01, 2025 מומי כהן   15.44 +6.09%
Aug 01, 2025 Liron Habler   15.37 +6.57%
Aug 01, 2025 עוזי אהרון   15.09 +8.55%
Aug 01, 2025 אילן פרגי   15.18 +7.91%
Jul 31, 2025 manuel Ferrero   15.68 Aug 06, 2025 @ 15.97 +1.85%
Jul 31, 2025 מנואל פוקס   15.75 +4.00%
Jul 31, 2025 אבי כהן   15.73 +4.13%
Jul 31, 2025 עמוס אלמסי   15.85 Aug 04, 2025 @ 15.65 -1.26%
Jul 31, 2025 Eli Shai   15.88 +3.15%
Jul 31, 2025 ראובן עידן   15.95 +2.70%
Jul 31, 2025 אפי חקק   15.92 +2.89%
Jul 31, 2025 אייל בכר   16.01 +2.31%
Jul 31, 2025 יש לל   16.05 Aug 04, 2025 @ 15.65 -2.49%
Jul 31, 2025 רן אורן   16.03 Aug 04, 2025 @ 15.65 -2.37%
Jul 31, 2025 Amnon Hilel   16.02 +2.25%
Jul 31, 2025 David Peretz   16.02 +2.25%
Jul 31, 2025 אמל אגבריה   16.17 -1.30%
Jul 31, 2025 גבריאל אסור   16.16 -1.36%
Jul 31, 2025 מיכאל גרינוולד   16.54 +0.97%
Jul 31, 2025 אבי פלד   16.62 -1.44%
Jul 31, 2025 Marino Correnti   16.92 Aug 04, 2025 @ 15.65 +7.51%
Jul 31, 2025 שמעון טל   16.95 Aug 04, 2025 @ 15.65 +7.67%
Jul 30, 2025 שאול בוקריץ   16.93 -3.25%
Jul 30, 2025 Ray Chetewy Ungar   16.92 -3.19%
Jul 30, 2025 Israel fridman   17.06 -3.99%
Jul 30, 2025 Ilan Shlomi   16.93 -3.25%
Jul 30, 2025 JR Almerino   16.84 -2.73%
Jul 30, 2025 אבי כהן   16.89 -3.02%
Jul 30, 2025 דוד גואטה   16.80 Aug 04, 2025 @ 15.65 -6.85%
Jul 30, 2025 עמי רביוד   16.70 -1.92%
Jul 30, 2025 Eli Morad   16.29 +0.55%
Jul 30, 2025 Shlomi Kariti   16.87 Aug 04, 2025 @ 15.65 -7.23%
Jul 30, 2025 Venancio Litico   16.57 Aug 04, 2025 @ 15.65 -5.55%
Jul 29, 2025 Yaniv Komemi   16.57 -1.15%
Jul 29, 2025 REUVEN KARGER   16.50 Aug 04, 2025 @ 15.65 +5.15%
Jul 29, 2025 Alfredo Millan   16.57 Aug 04, 2025 @ 15.65 -5.55%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Comments

Write your thoughts about Teva Pharma Industries Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email